Kategoria BISAC: Science >> Life Sciences - Biochemistry

Microbial biotechnology is an emerging field with applications in a broad range of sectors involving food security, human nutrition, plant protection and overall basic research in the agricultural sciences. The environment has been sustaining the burden of mankind from time immemorial, and our indiscriminate use of its resources has led to the degradation of the climate, loss of soil fertility, and the need for sustainable strategies. 

Collagen: Structure and Mechanics provides a cohesive introduction to this biological macromolecule and its many applications in biomaterials and tissue engineering.

Graduate students and postdoctoral researchers in the fields of materials, (bio-)engineering, physics, chemistry and biology will gain an understanding of the structure and mechanical behavior of type I collagen and collagen-based tissues in vertebrates, across all length scales from the molecular (nano) to the organ (macro) level. Written in a clear and didactic manner, this volume includes current knowledge on the...

Giving a fresh, substantial and in-depth overview of the topic, this book brings together the latest results in the field of metabolomics. It comprehensively presents the current state of the metabolomics field by underscoring experimental methods, analysis techniques, standardization practices, and advances in specific model systems. As a result, it helps to significantly broaden our perspective on the principles and strategies underpinning this emerging field.

This book critically reviews the evolutionary origin and the functional mechanisms responsible for sexual dimorphism in response to infection. It delineates areas where knowledge is lacking and highlights future avenues of research.

There have been tremendous advancements in application of modeling and simulation (M&S) in drug development during the last decade. The pharmaceutical companies started to pay more attention to implement simulation exercises in drug development in order to achieve cost effectiveness. The Food and Drug Administration (FDA) published a white paper titled, Critical Path Initiatives, in March 2004. This puts forward model based drug development that calls for use of quantitative M&S to facilitate informed decisions. The European Medicines Agency (EMEA) also encourages use of simulations in...